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DOI 10.1016/j.immuni.2011.11.011SUMMARY IL-17, a signature cytokine secreted by Th17 cells, is generallyInnate lymphoid cells (ILCs) expressing the nuclear
receptor RORgt are essential for gut immunity pre-
sumably through production of interleukin-22 (IL-22).
The molecular mechanism underlying the develop-
ment of RORgt+ ILCs is poorly understood. Here, we
have shown that the aryl hydrocarbon receptor (Ahr)
plays an essential role in RORgt+ ILC maintenance
and function. Expression of Ahr in the hematopoietic
compartment was important for accumulation of
adult but not fetal intestinal RORgt+ ILCs. Without
Ahr, RORgt+ ILCs had increased apoptosis and less
production of IL-22. RORgt interacted with Ahr and
promoted Ahr binding at the Il22 locus. Upon IL-23
stimulation, Ahr-deficient RORgt+ ILCs had reduced
IL-22 expression, consistent with downregulation of
IL-23R in those cells. Ahr-deficient mice succumbed
to Citrobacter rodentium infection, whereas ectopic
expression of IL-22 protected animals from early
mortality. Our data uncover a previously unrecognized
physiological role for Ahr in promoting innate gut
immunity by regulating RORgt+ ILCs.
INTRODUCTION
The aryl hydrocarbon receptor (Ahr) is a ligand-dependent tran-
scription factor. Upon ligand binding, Ahr translocates into the
nucleus and dimerizes with its partner, the aryl hydrocarbon
receptor nuclear translocator (Arnt), to induce target gene
transcription. Ahr is best known to mediate the effects of envi-
ronmental toxins (e.g., dioxin), yet its physiological role and
endogenous ligands remain elusive (Stevens et al., 2009).
Ahr has been previously shown to be involved in T cell
differentiation and function (Apetoh et al., 2010; Gandhi et al.,
2010; Kimura et al., 2008; Quintana et al., 2008; Veldhoen
et al., 2008). For example, Ahr activation enhances the differen-
tiation of T helper 17 (Th17) cells, a subset of CD4+ T cells that
express the cytokines interleukin-17 (IL-17) (also known as
IL-17A), IL-17F, and IL-22, thereby exacerbating in vivo Th17
cell-mediated autoimmunity (e.g., EAE) (Veldhoen et al., 2008).92 Immunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc.considered to play a pathogenic role in autoimmunity (Korn et al.,
2009). However, in the gut, IL-17 can be either detrimental
or protective, presumably depending on the different mouse
models of disease (O’Connor et al., 2010). IL-22, a member of
the IL-10 family of cytokines, works exclusively on nonhemato-
poietic cells to exert its biological functions (Ouyang et al.,
2011). IL-22 has been shown to induce the production of antimi-
crobial peptides and mucins by epithelial cells, thus playing an
important role in maintaining mucosal immunity and integrity
(Aujla et al., 2008; Sugimoto et al., 2008; Zheng et al., 2008).
Recent studies suggest that IL-22 can be produced not only
by Th17 cells but also by certain innate immune cells in the gut
(Colonna, 2009). Among them is a recently identified subset of
nonconventional natural killer (NK) cells that are present in the
intestinal lamina propria and that secrete large amounts of
IL-22. These cells have cell surface expression of NKp46 and
low amounts of NK1.1 and have been given different names
(e.g., NK-22, NCR22, NKR-LTi, or NKp46+ ILC) (Sawa et al.,
2010; Spits and Di Santo, 2011). In this paper, we use the term
NK-22 to denote these cells. Lineage marker-negative lymphoid
tissue inducer (LTi) cells, originally described to promote
lymphoid organogenesis, have also been found to secrete
IL-22 and IL-17 in adult mice and humans (Crellin et al., 2010;
Cupedo et al., 2009; Eberl et al., 2004; Mebius, 2003; Takatori
et al., 2009). LTi cells in the gut represent a heterogeneous
population of cells either with (LTi4) or without (LTi0) CD4 expres-
sion (Sawa et al., 2010). A common characteristic of the innate
lymphoid cells (ILCs) (e.g., NK-22 and LTi cells) is the expression
of RORgt, a transcription factor critical for the developmental
programs of these cells. RORgt+ ILCs are abundantly present
in the intestinal lamina propria and produce IL-22 and/or IL-17
that are important for mucosal immunity against certain extracel-
lular pathogens such as Citrobacter rodentium (Mangan et al.,
2006; Ota et al., 2011; Tumanov et al., 2011; Wang et al., 2010;
Zheng et al., 2008). Transferring wild-type LTi4 cells has been
recently shown to provide innate immunity toC. rodentium infec-
tion in mice, highlighting the crucial role of RORgt+ ILCs in innate
immune responses (Sonnenberg et al., 2011). Although it is clear
that RORgt+ ILCs play an important role in gut immunity
(Colonna, 2009; Cua and Tato, 2010), transcriptional regulation
of RORgt+ ILCs remains to be determined.
Ahr is expressed in NK-22 cells and LTi cells (Colonna, 2009;
Cua and Tato, 2010); however, there is little known about the
Immunity
Ahr Regulates RORgt+ ILCs in the Gutrole of Ahr in the development and/or function of RORgt+ ILCs.
In this report, we have discovered that Ahr regulates the accu-
mulation of RORgt+ ILCs in the gut. RORgt+ ILCs had increased
apoptosis and their number was markedly reduced in adult but
not fetal intestines of Ahr-deficient mice. Ahr was also required
for the function of RORgt+ ILCs, as shown by the fact that it
regulated IL-22 expression. RORgt interacted with Ahr and
facilitated the recruitment of Ahr to the Il22 locus. Il23r ex-
pression in RORgt+ ILCs was downregulated in the absence of
Ahr, consistent with the decreased production of IL-22 by
Ahr-deficient RORgt+ ILCs upon stimulation with IL-23. Because
of impaired maintenance and function of RORgt+ ILCs, Ahr-
deficient mice succumbed toC. rodentium infection. Exogenous
expression of IL-22 protected Ahr-deficient mice from infection.
Thus, our data reveal a previously unknown protective function
of Ahr in orchestrating the gut innate immunity.
RESULTS
RORgt+CD3– Non-T Cells Are a Major Source
of Intestinal IL-22 that Is Regulated by Ahr
Weexamined cytokine expression in the intestinal lamina propria
leukocytes (LPLs) isolated from Ahr-deficient (Ahr/) mice and
their littermate control wild-type (Ahr+/+) mice. In Ahr+/+ mice,
innate-like lymphocytes (ILCs) (CD3 negative) produced more
IL-22 on a per-cell basis compared to CD3+ cells (Figure 1A).
Furthermore, IL-22 was mostly produced by RORgt+ cells, con-
sistent with the important role of RORgt in regulating IL-22
expression (Ouyang et al., 2011). Compared to those in Ahr+/+
mice, intestinal LPLs in Ahr/ mice had markedly decreased
expression of IL-22, especially CD3– non-T cells, indicating
that Ahr is important for gut IL-22 expression (Figure 1A).
Although IL-17 production by CD3+ T cells is not dependent on
Ahr, a reduction of IL-17 produced by CD3– intestinal LPLs in
Ahr/ mice was consistently observed (Figure 1B). Of note,
wild-type CD3+ T cells in the small intestine produce more
IL-22 and IL-17 than those in the large intestine (Figures 1A
and 1B), in agreement with the notion that Th17 cells are more
abundant in the small intestine (Ivanov et al., 2006, 2009).
A decrease in RORgt+CD3 cells in Ahr/ mice (Figures 1A
and 1B) prompted us to examine the direct regulation of
cytokine expression by Ahr. We gated on RORgt+ cells in the
intestines and examined IL-22 and IL-17 production by intracel-
lular staining. IL-22 expression was consistently decreased in
RORgt+ cells in the absence of Ahr, indicating that Ahr may
directly regulate IL-22 production by RORgt+ cells in the gut
(Figure 1C). In contrast, the absence of Ahr had less effect on
IL-17 expression when gating on RORgt+ cells, suggesting that
the reduction of IL-17 expression by CD3 cells in Ahr/ mice
is mainly due to fewer RORgt+ cells (Figure 1D). These data
indicate that RORgt+ ILCs in the gut are main producers of
IL-22 and are sensitive to genetic loss of Ahr. We therefore focus
hereafter on the role of Ahr in RORgt+ ILCs.
Ahr Deficiency Leads to Decreased Number of RORgt+
ILCs in the Gut
To examine RORgt expression in different LPL populations, we
generated Rorcgfp/+Ahr/ and Rorcgfp/+Ahr+/+ littermate mice
in which RORgt expression was marked by GFP (Eberl et al.,2004). We stained both the large and small intestinal LPLs
with CD3, CD4, and NKp46 antibodies to examine RORgt+
ILCs (Figure 2A). Both the percentage and number of NK-22 cells
(CD3NKp46+GFP(RORgt)+), LTi4 cells (CD3
NKp46CD4+
GFP(RORgt)+), and LTi0 cells (CD3
NKp46CD4GFP(RORgt)+)
in the intestines were significantly decreased in Ahr/ mice
(Figures 2A–2C). When intracellular staining with RORgt-
specific antibody was performed, there was a similar reduction
of RORgt+ ILCs (i.e., NK-22, LTi4, and LTi0 cells) in Ahr
/ mice
compared to Ahr+/+ mice (data not shown). Together, these
data suggest that Ahr is important for the accumulation of
RORgt+ ILCs in the gut.
To determine the developmental stage at which Ahr is impor-
tant for promoting RORgt+ ILCs, we next examined the effect of
Ahr deletion on RORgt+ ILC populations during ontogeny. There
were no RORgt+NKp46+ cells in E17.5 fetal intestines, consistent
with the observation that NK-22 cells appear late after birth
(Figure 2D; Figure S1 available online; Sawa et al., 2010), yet
abundant LTi4 and LTi0 cells were found in the fetal intestines
(Figure 2D). In contrast to the significant decrease of LTi cells
in the LPLs of adult Ahr/ mice, the frequency of LTi cells in
the fetal intestines isolated from Ahr/ embryos was similar to
those from littermate control embryos, suggesting that Ahr is
dispensable for the development of LTi cells in the fetal
intestines (Figures 2D and 2E). A decrease in RORgt+ ILCs
(NK-22, LTi4, and LTi0 cells) from Ahr
/ mice was not evident
until the weaning age of week 3 (Figures S1A and S1B),
suggesting that environmental stimuli (e.g., gut flora or food)
contribute to the development of RORgt+ ILCs via the action
of Ahr. Although the endogenous Ahr ligands remain elusive,
6-formylindolo[3,2-b]carbazole (FICZ), a tryptophan photoprod-
uct, has been proposed to be a physiological agonist for
Ahr (Nguyen and Bradfield, 2008). In vivo treatment of FICZ
significantly increased the accumulation of RORgt+ ILCs in
Ahr+/ or Ahr+/+ mice but not in Ahr/ mice, consistent with
the important role of Ahr signaling in RORgt+ ILC development
(Figures 2F and 2G).
Deficiency of Ahr in the Hematopoietic Compartment
Affects the Development of RORgt+ ILCs in the Gut
Real-time reverse transcription PCR (RT-PCR) analysis indicated
that similar to intestinal Th17 cells, RORgt+ ILCs expressed high
amounts of Ahr (Figure S1C). However, because Ahr is broadly
expressed by many cell types (Harper et al., 2006), it remained
to be determined whether the decrease of RORgt+ ILCs in the
gut of Ahr/ mice was due to defects in hematopoietic cells or
those in other cell types. It has been recently reported that
intestinal RORgt+ ILCs are derived from hematopoietic
precursor cells in the bone marrow (Sawa et al., 2010).
Therefore, we developed chimeras by transferring bone marrow
cells isolated from either Rorcgfp/+Ahr+/+ or Rorcgfp/+Ahr/
littermate mice into lethally irradiated wild-type C57BL/6 mice.
Consistent with the published data (Sawa et al., 2010),
bone marrow cells isolated from either Rorcgfp/+Ahr+/+ or
Rorcgfp/+Ahr/ donor mice did not express GFP (data not
shown). After bone marrow transfer, however, donor-derived
RORgt+ cells (marked by GFP expression) were readily detect-
able in the intestinal lamina propria of C57BL/6 hosts (Figures
3A and 3B). Donor-derived NK-22, LTi4, and LTi0 cells were allImmunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc. 93
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Figure 1. RORgt+ ILCs Are the Major Source of Intestinal IL-22 that Is Dependent on Ahr
Intestinal LPLs were stimulated by PMA and ionomycin for 4 hr.
(A and B) RORgt, IL-22, and IL-17 expression in CD3 or CD3+ cells were analyzed by flow cytometry.
(C and D) Frequencies of IL-22- and IL-17-expressing cells in the RORgt+ gated cell populations of the large (LI) and small (SI) intestines are shown. Horizontal
lines represent the mean. **p < 0.01; ***p < 0.001. Error bars represent SEM. Experiments were independently repeated at least three times.
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Ahr Regulates RORgt+ ILCs in the Gutdecreased in the mice receiving Rorcgfp/+Ahr/ bone marrow
cells compared to the mice receiving Rorcgfp/+Ahr+/+ bone mar-
row cells, whereas the number of donor-derived GFP(RORgt)+
CD3+ T cells was less affected (Figures 3A and S2A). On the
contrary, Rorcgfp/+Ahr+/+ bone marrow cells developed equally
well into RORgt+ ILCs and produced comparable amount of94 Immunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc.IL-22 when transferred into either Ahr+/+ or Ahr/ litter-
mate hosts (Figures 3B and S2B and data not shown).
Together, these data indicate that the impaired accumulation
of RORgt+ ILCs in the gut of Ahr/ mice is due to defects
caused by the deficiency of Ahr in the hematopoietic
compartment.
Immunity
Ahr Regulates RORgt+ ILCs in the GutAlthough Ahr was required for RORgt+ ILC development as
examined with Ahr+/+ and Ahr/ mice that were littermate
controlled and cohoused, loss of Ahr expression in hemato-
poietic cells might affect the composition of gut microbiota.
The difference in microbiota might in turn contribute to the
developmental defect of ILCs in Ahr/ mice. To address these
possibilities, we performed bacterial 16S rRNA gene sequencing
of fecal pellets collected from Ahr+/+ or Ahr/ mice. Our data
showed that the major composition of intestinal flora of Ahr/
mice was similar to that of Ahr+/+ littermate mice (Figure S2C).
We further examined the development of ILCs in Ahr/ and
Ahr+/+ littermate mice upon antibiotic treatment. As expected,
IL-17 expression was reduced upon antibiotic treatment
(Figure S2D). However, the defective accumulation of RORgt+
ILCs was evident in Ahr/ mice with or without antibiotic
treatment (Figure 3C). Together, these data suggest that
the defect of RORgt+ ILCs in Ahr/ mice is less likely due to
perturbation of the gut flora.
To examine whether Ahr in other cells (e.g., T cells)
indirectly affects the development of RORgt+ ILCs, we gener-
ated Ahr/Rag1/ mice in which T and B cells are absent
because of Rag deficiency. Lack of Ahr led to marked reduction
of intestinal RORgt+ ILCs in Ahr/Rag1/ mice, suggesting
that Ahr plays a direct role in the development of RORgt+
ILCs independently of adaptive immune cells (e.g., Th17 cells)
(Figure 3D).
Ahr Is Important for the Survival of Intestinal RORgt+
ILCs
To determine the mechanism by which Ahr regulates the devel-
opment of RORgt+ ILCs in the gut, we stained LPLs with 7-AAD
and Annexin V to examine apoptosis. In contrast to other cell
populations in the gut, CD3RORgt+ innate cells isolated from
Rorcgfp/+Ahr/ mice consistently showed higher Annexin V
staining (Figures 4A and S3A), indicating that intestinal RORgt+
ILCs are more prone to apoptosis without Ahr. Consistently,
the expression of antiapoptotic genes (e.g., Bcl2 and Bcl2l1)
was decreased in Ahr/ ILCs as shown by real-time RT-PCR
(Figure 4B). To determine whether the loss of RORgt+ ILCs in
Ahr/ mice is due to decreased cell expansion, we examined
the proliferation of RORgt+ ILCs by Ki67 staining. RORgt+ ILCs
from Ahr/ mice displayed a similar rate of proliferation
compared to wild-type cells (Figure S3B). Together, these
data suggest that survival defect rather than impaired cell
expansion accounts for the decrease of RORgt+ ILCs in Ahr/
mice.
IL-7 signaling pathway has been shown to stabilize RORgt
expression in ILCs and may be required for survival and mainte-
nance of RORgt+ ILCs (Meier et al., 2007; Vonarbourg et al.,
2010). Consistent with enhanced apoptosis of RORgt+ ILCs in
the absence of Ahr, we observed a reduction of IL-7 in the large
intestine of Ahr/ mice (Figure S3C). IL-7R mRNA and protein
(CD127) expression were also decreased in Ahr-deficient ILCs
(Figures S3D and S3E). These data suggest that although
engagement of IL-7R sustains RORgt+ ILCs in wild-type
mice when IL-7 is generated in the presence of microflora
(Vonarbourg et al., 2010), the defect in the maintenance of Ahr-
deficient RORgt+ ILCs may be in part due to the compromised
IL-7 and IL-7R expression.Ahr Is Important for Production of IL-22 by RORgt+ ILCs
under Steady-State Conditions
Fewer RORgt+ ILCs in Ahr/ mice led to an overall reduction
of IL-22 expression (Figure 1). To determine whether Ahr
directly regulates IL-22 expression in each individual RORgt+
ILC population, we examined IL-22 protein in the remaining
RORgt+ ILCs in Ahr/ mice by intracellular staining
(Figure 5A). Production of IL-22 by NK-22 cells, LTi4 cells, or
LTi0 cells was impaired in Ahr
/ mice compared to Ahr+/+
mice (Figure 5A), suggesting that Ahr regulates the ability of
those cells to produce IL-22. Intestinal CD3–NKp46+NK1.1lo
cells but not CD3NKp46+NK1.1hi cells contain NK-22 cells
and produce large amounts of IL-22 that was also greatly
reduced in Ahr/ mice (Figures S4A and S4B), consistent
with the role of Ahr in regulating IL-22 expression in NK-22
cells. Accordingly, the induction of RegIIIg, an antimicrobial
peptide produced by IECs and involved in mucosal homeo-
stasis, was significantly reduced in Ahr/ mice, in agreement
with the role for IL-22 in the regulation of RegIIIg expression
(Figure S4C).
In contrast to Th17 cells in which Ahr promotes IL-17 expres-
sion (Kimura et al., 2008; Veldhoen et al., 2008), IL-17
produced by residual RORgt+ ILCs in the large intestine of
Ahr/ mice was not significantly changed upon phorbol myr-
istate acetate (PMA) plus ionomycin activation, indicating that
the expression of IL-17 in ILCs is less dependent on Ahr in
the gut (Figure 5A). CCR6, a target gene of RORgt, is highly
expressed by RORgt+ cells and presumably regulates the
migration of these cells via CCL20 (Acosta-Rodriguez et al.,
2007; Annunziato et al., 2007; Bouskra et al., 2008; Hirota
et al., 2007; Martin et al., 2009; Takatori et al., 2009). The
absence of Ahr caused a slight but significant decrease of
CCR6 expression by LTi0 cells, suggesting a role for Ahr in
modulation of CCR6 (Figure 5A). Nevertheless, the expression
of CCL20, the ligand for CCR6, was normal in the intestinal
epithelial cells (IECs) of Ahr/ mice (Figure S4D). Consistent
with the protein data (Figure 5A), marked reduction of IL-22
but not IL-17 mRNA was observed in Ahr-deficient RORgt+
cell populations freshly isolated from the gut under steady-
state conditions (Figure 5B). Together, these data
demonstrate that Ahr selectively regulates IL-22 expression in
RORgt+ ILCs.
RORgt Interactswith Ahr andEnhances the Recruitment
of Ahr to the Il22 Locus
After searching for transcription factor binding sites at the
Il22 locus, we found multiple Ahr-responsive elements
(AhRE) that are clustered with ROR-responsive elements
(RORE), among which are those at the promoter and intron 1
of the Il22 gene, suggesting that Il22 may be a direct target
gene of Ahr and/or RORgt (Figure 5C). To examine
transcription factor binding at the Il22 locus, we took
advantage of EL4 cells expressing the double flag peptide
(DTFC), double flag-tagged RORgt (DFTC-RORgt), or double
flag-tagged constitutively active Ahr (DFTC-CA-Ahr). CA-Ahr
lacks the PAS-B domain, enabling it to constitutively dimerize
with Arnt, bind to DNA, and activate transcription in a ligand-
independent manner (McGuire et al., 2001). A chromatin
immunoprecipitation (ChIP) assay with flag antibodiesImmunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc. 95
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Figure 2. Ahr Is Important for the Accumulation of RORgt+ ILCs in the Gut
(A) GFP(RORgt) and NKp46 expression were analyzed in intestinal LPLs by flow cytometry after gating on CD3 cells. GFP(RORgt) and CD4 expression were
analyzed after gating on CD3NKp46 cells. Data are representative of at least three independent experiments.
(B) Percentage of NK-22 cells (CD3NKp46+GFP(RORgt)+) in the CD3 population, as well as percentages of LTi4 cells (CD3
NK46CD4+GFP(RORgt)+) and LTi0
cells (CD3NKp46CD4GFP(RORgt)+) in the CD3NKp46 cell population of the large (LI) and small (SI) intestinal LPLs isolated from Rorcgfp/+Ahr+/+ (WT) and
Rorcgfp/+Ahr/ (KO) mice are shown.
(C) Absolute numbers of NK-22, LTi4, and LTi0 cells in the LI and SI LPLs of WT and KO mice are shown.
(D) Intestinal LPLs were isolated from 17.5 day of embryos (E17.5) of the indicated genotypes. NK-22, LTi4, and LTi0 cells were analyzed by flow cytometry. Data
are representative of two independent experiments.
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Ahr Regulates RORgt+ ILCs in the Gutshowed enhanced binding of RORgt at the Il22 locus in cell
lines expressing DFTC-RORgt, suggesting that Il22 is a direct
target gene of RORgt (Figure 5D). In contrast, no consistent
enhancement of Ahr binding at the Il22 locus was detected
by ChIP analysis with DFTC-CA-Ahr-expressing cell lines,
whereas binding of Ahr at a known target gene (i.e., Cyp1a1)
(Hankinson, 2005) could be readily detected (Figure 5E). The
recruitment of CA-Ahr to the Il22 locus but not the Cyp1a1
locus was markedly enhanced when RORgt was coexpressed
in DFTC-CA-Ahr-expressing cells, indicating that RORgt facili-
tates Ahr binding at the Il22 locus (Figure 5E). By using a
coimmunoprecipitation assay, we detected the interaction
between Ahr or CA-Ahr and RORgt (Figure 5F). Furthermore,
individual expression of Ahr or RORgt induced IL-22, but coex-
pression of Ahr and RORgt synergistically upregulated IL-22
mRNA (Figure 5G). Together, these data suggest that the
cooperativity between Ahr and RORgt promotes IL-22
expression.
IL-23-Induced IL-22 and IL-17 Expression in RORgt+
ILCs Are Impaired in Ahr–/– Mice
Given that IL-23 is shown to promote the production of IL-22 by
RORgt+ cells (Cella et al., 2009; Sanos et al., 2009; Satoh-
Takayama et al., 2008), we sorted ILCs (CD3GFP(RORgt)+)
from Ahr+/+ or Ahr/ littermate mice and examined IL-22
expression by ELISA. Although Ahr-deficient RORgt+ ILCs ap-
peared to be responsive to IL-23 stimulation, they had a marked
reduction in IL-22 expression compared to wild-type cells upon
IL-23 stimulation (Figure 6A), consistent with the intracellular
staining data with total LPLs (Figure 6B). Although IL-17 produc-
tion by RORgt+ ILCs under these culture conditions was low, the
expression was augmented by in vitro activation with PMA plus
ionomycin and further enhanced by IL-23 treatment. Similar to
the reduction of IL-22, IL-17 production by Ahr-deficient ILCs
was decreased upon IL-23 stimulation compared to that by
wild-type ILCs (Figure S5). Together, these data suggest that
Ahr is important for IL-23-stimulated IL-22 and IL-17 expression
in RORgt+ ILCs. To determine whether IL-23 signaling is defec-
tive in the absence of Ahr, we sorted RORgt+ cells from the intes-
tinal lamina propria and examined the expression of IL-23R by
real-time RT-PCR. IL-23R expression was markedly reduced
in NK-22 cells and LTi cells isolated from Ahr/ mice, suggest-
ing that Ahr regulates IL-23R expression in RORgt+ ILCs
(Figure 6C). Recent data suggest that RORgt+ innate cells
(e.g., LTi cells) in the spleen produce IL-22 (Sonnenberg et al.,
2011; Takatori et al., 2009). Indeed, CD4+CD11c innate
lymphoid cells in the spleen of Rag1/ mice expressed IL-22
that was further enhanced by IL-23 treatment. IL-22 production
by CD4+CD11c splenocytes was greatly reduced in
Rag1/;Ahr/ mice (Figure 6D), suggesting that the
production of IL-22 by ILCs outside the intestines is also depen-
dent on Ahr.(E) Percentages of LTi4 cells and LTi0 cells isolated from the E17.5 intestines of R
(F) RORgt+ cells in CD3 population of LI and SI LPLs isolated from littermatemice
cytometry. Data are representative of two independent experiments.
(G) Percentages of NK-22, LTi4, and LTi0 cells from LPLs isolated from Rorc
gfp/+
(B, C, E, and G) Horizontal lines show the mean. *p < 0.05; **p < 0.01; ***p < 0.0
See also Figure S1.Ahr Regulates Host Immunity to C. rodentium
in an IL-22-Dependent Manner
Controlling C. rodentium is dependent on IL-23 signaling and
requires early production of IL-22 in the host (Ota et al., 2011;
Sonnenberg et al., 2011; Tumanov et al., 2011; Zheng et al.,
2008). Our data showed that Ahr-deficient RORgt+ ILCs made
less IL-22 upon IL-23 stimulation. Therefore, we used the model
of C. rodentium infection to study the impact of Ahr on the
host responses during inflammation. When infected with
C. rodentium, Ahr/ mice rapidly lost body weight and died
by day 10 postinfection, whereas no weight loss or death was
observed in the control mice (Figures 7A and 7B). Accordingly,
on day 5, Ahr/ mice had higher C. rodentium colony counts
in their feces than did Ahr+/+ littermate mice, indicating that Ahr
is crucial for controlling the bacterial infection (Figure 7C). We
next examinedwhether ectopic expression of IL-22 could rescue
Ahr/mice from death. To this end, we infected both wild-type
and Ahr/ mice with C. rodentium and administered a plasmid
expressing IL-22 or a control empty plasmid to animals by hydro-
dynamic injection. 60% of Ahr/ mice receiving IL-22 expres-
sion plasmid via hydrodynamic injection survived infection
beyond day 17 and had much less weight loss compared to
Ahr/ mice receiving control plasmid (Figures 7D and 7E).
Both wild-type and Ahr/ mice receiving IL-22 plasmid had
reduced bacterial counts in their feces compared to mice
receiving the control plasmid, consistent with the crucial role of
IL-22 in controlling infection (Figure 7F). Collectively, these
data demonstrate that impaired IL-22 production is the main
reason for the high bacterial load and death of Ahr/ mice
during C. rodentium infection.
DISCUSSION
The development of RORgt+ innate lymphoid cells (e.g., LTi cells)
is dependent on several transcription factors such as RORgt
(Eberl et al., 2004), TOX (Aliahmad et al., 2010), Ikaros (Wang
et al., 1996), and the E-protein inhibitor Id2 (Boos et al., 2007;
Yokota et al., 1999). Unlike the aforementioned transcription
factors, Ahr is unique in that it is not required for the development
of fetal LTi cells, consistent with the normal development of
secondary lymphoid organs (i.e., lymph nodes) and tertiary
lymphoid aggregates (e.g., Peyer’s patches) in the intestines of
Ahr/ mice (data not shown). Instead, adult Ahr/ mice have
markedly reduced numbers of RORgt+ ILCs in both the small
and the large intestines.
Although the development of Th17 cells in the small intestine
can be promoted by specific commensal gut flora (e.g.,
segmented filamentous bacteria) (Gaboriau-Routhiau et al.,
2009; Ivanov et al., 2009), it is still under debate whether the
development of NK-22 cells requires intestinal symbionts
(Reynders et al., 2011; Sanos et al., 2009; Satoh-Takayama
et al., 2008; Sawa et al., 2010; Vonarbourg et al., 2010). It hasorcgfp/+Ahr+/ (Ctrl) or Rorcgfp/+Ahr/ (KO) mice are shown.
of the indicated genotypes after DMSO or FICZ injection were analyzed by flow
Ahr+/+ or Rorcgfp/+Ahr+/ mice after DMSO or FICZ injection are shown.
01. Error bars represent SEM.
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Figure 3. Reduction of RORgt+ ILCs in Ahr–/– Mice Is Attributed to a Hematopoietic Defect
(A and B) Bone marrow cells from mice of the indicated genotypes were transferred into lethally irradiated recipient mice. NK-22 (CD3NKp46+GFP(RORgt)+),
LTi4 (CD3
NK46CD4+GFP(RORgt)+), LTi0 (CD3
NKp46CD4GFP(RORgt)+), and RORgt+ T (CD3+TCR-b+GFP(RORgt)+) cells were analyzed by flow cytometry.
Data are representative of three independent experiments.
(C) Large intestinal LPLs were isolated from mice untreated or treated with antibiotics for 10 days or 8 weeks. Percentages of NK-22, LTi4, and LTi0 cells were
analyzed by flow cytometry. Data are representative of two experiments.
(D) Percentages of NK-22, LTi4, and LTi0 cells were analyzed by flow cytometry. Data are representative of three independent experiments.
See also Figure S2.
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Ahr Regulates RORgt+ ILCs in the Gutbeen recently reported that the development of at least some
RORgt+ ILCs is independent of gut microbiota, because germ-
free mice or mice treated with antibiotics after birth have nor-98 Immunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc.mal development of RORgt+ LTi cells (Sawa et al., 2010). The
absence of Ahr might cause changes in the gut microbiota,
which in turn could influence the development of RORgt+ ILCs
ACD3+GFP(ROR t)+
CD3+GFP(ROR t)
CD3 GFP(ROR t)+
CD3 GFP(ROR t)
Annexin V
7-
AA
D
Rorc
gfp/+;
Ahr 
+/+
Rorc
gfp/+;
Ahr 
/
Small intestine
Rorc
gfp/+;
Ahr 
+/+
Rorc
gfp/+;
Ahr 
/
Large intestine
0
2
4
6
8
10
Bc
l2
l1
 m
R
N
A
Bc
l2
 m
R
N
A
0
2
4
6
8
10
Th17 NK-22 LTi
Rorc
gfp/+; Ahr +/+
Rorc
gfp/+; Ahr /
Rorc
gfp/+; Ahr +/+
Rorc
gfp/+; Ahr /
Th17 NK-22 LTi
B
Figure 4. Ahr-Deficient RORgt+ ILCs Have
Enhanced Apoptosis
(A) Intestinal LPLs were examined by flow cyto-
metry for CD3, GFP, and apoptosis markers
(Annexin V and 7-AAD). Data are representative of
three independent experiments.
(B) Th17 (CD3+TCRb+CD4+GFP(RORgt)+), NK-
22 (CD3TCRbNKp46+GFP(RORgt)+), and LTi
(CD3TCRbNKp46GFP(RORgt)+) cells were
sorted from large intestinal LPLs by flow cyto-
metry. Bcl2 and Bcl2l1 mRNA expression in each
cell population were analyzed by real-time RT-
PCR. RNA samples were pooled from three to
four mice in each experiment. Data are represen-
tative of two independent experiments. Error bars
represent SEM of triplicate samples of real-time
RT-PCR.
See also Figure S3.
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Ahr Regulates RORgt+ ILCs in the Gutin a cell-extrinsic manner. However, we discovered that the
development of RORgt+ ILCs was impaired when Ahr-deficient
bone marrow cells were transferred to wild-type mice, whereas
transfer of wild-type bone marrow cells completely restored
the number of RORgt+ ILCs in the gut of Ahr/ mice. Fecal
bacterial 16S rRNA gene analysis further revealed no major
difference in bacterial composition between wild-type and
Ahr/ mice. These data argue that Ahr regulates intestinal
RORgt+ ILCs in a cell-autonomous manner and that cell-Immunity 36, 92–10extrinsic effects (e.g., the potential differ-
ences in gut flora between Ahr/ mice
and wild-type mice) are less likely to
contribute to the reduction of RORgt+
ILCs in the gut of Ahr/ mice. Of note,
the decrease of RORgt+ ILCs in Ahr/
mice became evident when mice were
close to weaning age, suggesting that
the colonization of gut microbiota may
regulate the function of Ahr. It is tempting
to speculate that endogenous ligands
generated by gut-resident bacteria acti-
vate Ahr and promote or sustain RORgt+
ILC development in wild-type mice but
fail to do so in Ahr/ mice. Indeed, it
has been shown that certain bacteria in
the gut generate metabolites from the
amino acid tryptophan to activate Ahr
in vitro (Perdew and Babbs, 1991).
Consistently, RORgt+ ILCs were
increased in wild-type mice but not in
Ahr/ mice upon exogenous agonist
FICZ administration. However, ligands
generated independently of gut flora by
metabolizing food product(s) and/or other
nondietary components (Nguyen and
Bradfield, 2008; Nguyen et al., 2009)
may also activate Ahr to promote ILC
development in vivo. Consistent with
this hypothesis, the defective accumula-
tion of RORgt+ ILCs was still apparent inAhr/mice upon antibiotic treatment. Thus, a definitive answer
awaits generation of germ-free Ahr/ mice, detailed character-
ization of gut flora, and identification and characterization of Ahr
ligand(s).
CCL20, a chemokine produced by IECs, controls the migra-
tion of cells expressing CCR6, a homing receptor important for
RORgt+ ILC migration to certain intestinal microenvironments
(Cook et al., 2000; Tanaka et al., 1999). Our data showing rela-
tively normal expression of CCL20 and CCR6 makes it unlikely4, January 27, 2012 ª2012 Elsevier Inc. 99
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Figure 5. Ahr Regulates the Function of NK-22 and LTi Cells to Produce IL-22
(A) IL-22, IL-17, and CCR6 expression in large intestinal NK-22, LTi4, and LTi0 cells were analyzed by flow cytometry. For IL-22 and IL-17 staining, cells were
stimulated for 4 hr with PMA and ionomycin. Data were derived from three to four pairs of littermate mice. *p < 0.05; **p < 0.01. Error bars represent SEM.
Experiments were repeated at least three times.
(B) Th17 (CD3+TCRb+CD4+GFP(RORgt)+), NK-22 (CD3TCRbNKp46+GFP(RORgt)+), and LTi (CD3TCRbNKp46GFP(RORgt)+) cells were sorted from LI and
SI LPLs by flow cytometry. IL-22 and IL-17mRNA expression in each cell population were directly analyzed by real-time RT-PCR. RNA samples were pooled from
three to four mice in each experiment. Data are representative of two independent experiments. Error bars represent SEM of triplicate samples of real-time
RT-PCR.
(C) AhREs and ROREs at the Il22 locus are shown.
(D) RORgt binding at the Il22 locus in EL4 stable cell lines expressing either flag peptide (DFTC) or flag-tagged RORgt (DFTC-RORgt) was monitored by flag ChIP
assay. The fold enrichment of RORgt binding at each locus was normalized to DFTC-empty EL4 cells. The Il12b and Il17 loci were used as negative and positive
controls, respectively. Error bars represent SEM of triplicate samples of real-time PCR. Data are representative of three independent experiments.
(E) Empty MIG (MIG) or RORgt-MIG were coexpressed by retroviral transduction in EL4 cell lines stably expressing either flag peptide (DFTC) or flag-tagged
CA-Ahr (DFTC-CA-Ahr). Ahr binding at the Il22 locus was monitored by flag ChIP assay. Data are representative of three independent experiments.
(F) Ahr physically interacted with RORgt. HEK293T cells were transiently transfected with the indicated expression constructs. Whole cell extracts were made
and subjected to anti-HA immunoprecipitation and subsequently immunoblotted with flag or HA antibodies. Data are representative of three independent
experiments.
(G) EL4 cells were transduced with retroviruses encoding RORgt and/or CA-Ahr. IL-22 mRNA expression was analyzed by real-time RT-PCR. Data are
representative of two independent experiments. Error bars represent SEM of triplicate samples of real-time RT-PCR.
See also Figure S4.
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Figure 6. IL-23-Induced IL-22 Expression Is Impaired in Ahr-Deficient Mice
(A) CD3GFP(RORgt)+ cells were sorted from large intestinal LPLs by flow cytometry. Equal numbers of cells (13 104) were stimulated with or without IL-23 for
24 hr without restimulation by PMA and ionomycin. The concentration of IL-22 in the supernatant was examined by ELISA. Error bars represented SEM of
triplicate samples. Data are representative of two independent experiments.
(B) Large intestinal LPLs were stimulated with or without IL-23 overnight without restimulation by PMA and ionomycin. Expression of IL-22 and RORgt in CD3
cells were analyzed by flow cytometry. Data are representative of three independent experiments.
(C) IL-23RmRNA expression in flow cytometry-sorted NK-22 (CD3TCRbNKp46+GFP(RORgt)+) and LTi (CD3TCRbNKp46GFP(RORgt)+) cells from LI and SI
LPLs was directly analyzed by real-time RT-PCR. RNA samples were pooled from three to four mice for each genotype. Data are representative of two inde-
pendent experiments.
(D) Splenocytes of the indicate genotypes were stimulated with or without IL-23 overnight without restimulation by PMA and ionomycin. Expression of IL-22 in
CD4+CD11c cells was analyzed by flow cytometry. Data are representative of two independent experiments.
See also Figure S5.
Immunity
Ahr Regulates RORgt+ ILCs in the Gutthat a migrational defect of RORgt+ ILCs to the lamina propria
could account for the reduction of intestinal RORgt+ ILCs in
Ahr/ mice. Consistently, it has been reported that CCR6 is
not required for the development of RORgt+ ILCs but is important
for the bacteria-induced generation of isolated lymphoid follicles
(ILFs) from cryptopatches, where most of the RORgt+ ILCs are
clustered (e.g., LTi cells) (Bouskra et al., 2008).
Although Ahr has been shown to be required for IL-22 expres-
sion, it was unknown whether the regulation is through a tran-
scriptional mechanism. Our data suggested that binding of Ahr
at the Il22 locus appeared to be weak without the aid of RORgt.
The recruitment of Ahr to the Il22 locus was markedly enhanced
by coexpression of RORgt, underscoring the essential function
of RORgt for the Ahr-directed IL-22 gene expression. Our data
further suggested that the cooperativity between Ahr and RORgt
to promote Il22 transcription may be mediated through protein-
protein interaction. Facilitated by RORgt, Ahr may achieveenhanced DNA binding activity, whereby directly binding to the
AhREs at the Il22 locus induces transcription. Alternatively, Ahr
may indirectly bind to ROREs through interaction with RORgt.
The detailed molecular mechanism by which Ahr orchestrates
with RORgt to regulate IL-22 expression in RORgt+ ILCs remains
to be determined. IL-23 signaling is important for the function of
ILCs during colitis inmice and in humans (Buonocore et al., 2010;
Geremia et al., 2011), presumably when large amounts of IL-23
are produced by antigen-presenting cells because of activation
of pattern recognition receptors. Ahr-deficient RORgt+ ILCs
had decreased expression of IL-23R and produced less IL-22
upon IL-23 stimulation. Thus, regulation of Il23r transcription
by Ahr in RORgt+ ILCs may have an important implication in
IL-22 expression during inflammation.
Ourdata showingAhr deficiency hadagreater in vivo impact on
gut ILCs than Th17 cells suggested that Ahr played amore impor-
tant role in intestinal RORgt+ ILC maintenance or survival. InImmunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc. 101
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Figure 7. Ectopic Expression of IL-22
Protects Ahr–/– Mice from C. rodentium
Infection
(A–C) Littermate mice of the indicated genotypes
were infected with C. rodentium.
(D–F) Ahr/ (KO) mice and Ahr+/ or Ahr+/+ (Ctrl)
littermate mice were infected with C. rodentium.
Six hours after infection, IL-22-expressing plasmid
(pRK-mIL-22, Genentech) or control vector (pRK)
was administered into the mice via hydrodynamic
injection.
(A and D) Survival rates were monitored at the
indicated time points.
(B and E) Body mass was monitored at the indi-
cated time points. Results are shown as mean
percentage of body weight change ± SEM. Data
were pooled from three to six mice for each
genotype (B) or for each treatment group (E). Mice
were excluded from analyses after the time of
death.
(C and F) Colony-forming unit (CFU) counts of
C. rodentium in the fecal pellets on day 5 after
infection were shown. Data were pooled from
three to six mice for each genotype (C) or for each
treatment group (F). Statistical analyses were
performed by Mann-Whitney test (C).
*p < 0.05; **p < 0.01; ***p < 0.001. Error bars
represent SEM. Data are representative of two
independent experiments.
Immunity
Ahr Regulates RORgt+ ILCs in the Gutaccordance with the notion, although Ahr is required for IL-22
production by in-vitro-differentiated Th17 cells in the presence
of Ahr ligand, it is not required for the expression of IL-17, a hall-
mark cytokine for Th17 cells (Veldhoen et al., 2008). Additional
T cell-restricted factors may thus compensate for the loss of Ahr
to drive RORgt-directed Th17 cell differentiation. It has been
shown that inactivationofAhr enhances IL-6production inmacro-
phages (Kimura et al., 2009), which may signal through Stat3 to
promote Th17 cell differentiation in vivo. It is also possible that
in vivo Th17 cell differentiation can be indirectly affected by
regulatory T (Treg) cells in which Ahr seems to play a complex
role (Quintana et al., 2008). Thus, the function of Ahr in steady-
state intestinal Th17 cell differentiation is yet to be determined.
Of note, although our data suggest that T cells make less IL-22
than RORgt+ ILCs on a per-cell basis under the steady-state
conditions in the gut, they can secrete high amounts of IL-22
under certain inflammatory conditions (e.g., C. rodentium infec-
tion). Indeed, in addition to the defects of RORgt+ ILCs, Ahr/
mice cannot mount effective Th17 cell responses in the gut at
the later stage of sublethal C. rodentium infection (unpublished
data). Ectopic expression of IL-22 rescuedAhr/mice fromearly
death during infection, highlighting IL-22 regulation as an impor-
tant mediator of Ahr’s protective role in gut immunity.
EXPERIMENTAL PROCEDURES
Mice
All mice used in this study were maintained in specific-pathogen-free facilities
at Northwestern University. The mice were littermate controlled and were102 Immunity 36, 92–104, January 27, 2012 ª2012 Elsevier Inc.6–10 weeks old unless otherwise indicated in the
text. The generation of mice was described in the
Supplemental Information. All studies with micewere approved by the Animal Care and Use Committee of Northwestern
University.
C. rodentium Infection and CFU Counts
C. rodentium infection was done by gavage and CFU counts of fecal bacteria
after infection was determined as described in the Supplemental Information.
In Vivo Ahr Agonist Treatment and Hydrodynamic Gene Delivery of
IL-22
12-day-old mice were injected with 0.5 mg FICZ or vehicle DMSO per day intra-
peritoneally for 6 days before analysis. Plasmid DNA was introduced into mice
via a hydrodynamic tail vein injection-based gene transfer technique as
described in the Supplemental Information.
Isolation of LPLs and IECs
The isolation of fetal, 1-week-old, and adult (R3 weeks) intestinal LPLs and
IECs was done as described in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
(methods for bone marrow transfer, antibiotic treatment, flow cytometry, anti-
bodies and ELISA, quantitative real-time RT-PCR, plasmids and retroviral
transduction of cell lines, ChIP assays, coimmunoprecipitation, western blot,
16S rRNA gene analysis, and statistical analysis), five figures, and one table
and can be found with this article online at doi:10.1016/j.immuni.2011.11.011.
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